Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support

American Journal of Case Reports

Volumn 14, Issue , 2013, Pages 116-119

  Nakashima, Hiroshi ^a   Umeyama, Yasuhiro ^a   Minami, Kazutoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Extracorporeal membrane oxygenation; Fulminant myocarditis; Immunosuppression

Indexed keywords

ADRENALIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE; DOPAMINE; INOTROPIC AGENT; METHYLPREDNISOLONE; NORADRENALIN; TROPONIN T;

ADULT; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CARDIOMEGALY; CASE REPORT; CONTINUOUS INFUSION; DISEASE COURSE; DISEASE RESISTANCE; DRUG ELUTING STENT; ELECTROCARDIOGRAM; EXTRACORPOREAL OXYGENATION; FULMINANT MYOCARDITIS; HEART ARREST; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE NECROSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LUNG CONGESTION; LUNG EDEMA; MAINTENANCE THERAPY; MALE; MYOCARDITIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; QRS COMPLEX; ST SEGMENT ELEVATION; THORAX RADIOGRAPHY;

EID: 84876757788     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.889109     Document Type: Article

References (11)

1. McCarthy RE III, Boehmer JP, Hruban RH et al: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. New Eng J Med, 2000; 342(10): 690-95
2. Berte B, Eyskens B, Meyfroidt G, Willems R: Bidirectional ventricular tachycardia in fulminant myocarditis. Europace, 2008; 10(6): 767-68
3. Kohno K, Aoyama N, Shimohama T et al: Resuscitation from fulminant myocarditis associated with refractory ventricular fibrillation. Jpn Circ J, 2000; 64(2): 139-43
4. Mirabel M, Luyt CE, Leprince P et al: Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med, 2011; 39(5): 1029-35
5. Hsu KH, Chi NH, Yu HY et al: Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. Eur J Cardiothorac Surg, 2011; 40(3): 682-88
6. Kindermann I, Barth C, Mahfoud F et al: Update on myocarditis. J Am Coll Cardiol, 2012; 59(9): 779-92
7. Frustaci A, Russo MA, Chimenti C: Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J, 2009; 30(16): 1995-2002
8. Moreels M, Delforge ML, Renard M: Fulminant myocarditis with dramatic response to corticoids. Acta Cardiol, 2010; 65(1): 97-99
9. Dennert R, Velthuis S, Westermann D et al: Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy. Antivir Ther, 2010; 15(4): 681-85
10. Nakashima H, Katayama T, Ishizaki M et al: Q wave and non-Q wave myocarditis with special reference to clinical significance. Jpn Heart J, 1998; 39(6): 763-74
11. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation, 1999; 99(8): 1091-100